Occurrence of New Helicobacter pylori Infections in Healthy, Helicobacter pylori-Negative Adults: A Prospective Observational Study

Article information

Korean J Helicobacter Up Gastrointest Res. 2026;26(3):300-306
Publication date (electronic) : 2026 September 8
doi : https://doi.org/10.7704/kjhugr.2026.0004
Center for Gastric Cancer, National Cancer Center, Goyang, Korea
Corresponding author Il Ju Choi, MD, PhD Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea E-mail: cij1224@ncc.re.kr
Received 2026 January 16; Revised 2026 March 2; Accepted 2026 April 3.

Abstract

Objectives

The annual incidence of new Helicobacter pylori infections evaluated by serological test in Korean adults has been reported to be 2.1%–3.3%. This study evaluated the rate of new H. pylori infections using the urea breath test (UBT) and the factors associated with new infection.

Methods

In this prospective observational study, we recruited participants from the National Cancer Screening Program who tested negative for H. pylori infection by both rapid urease test and histology between November 2007 and December 2014. The participants underwent the UBT to check their follow-up H. pylori infection status from August 2015 to December 2017. The primary outcome of this study was new H. pylori infection.

Results

A total of 192 participants were enrolled in this study. During the mean follow-up of 4.1 years from the initial negative tests for H. pylori infection, a new infection occurred in six participants (3.1%, 6/192 participants). According to analyses using the logistic regression model, age (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.02–1.26) and corpus atrophy (OR, 9.83; 95% CI, 1.59–60.98) were associated with the new H. pylori infection in univariate analyses. However, no significant factors were identified in multivariate analysis.

Conclusions

New H. pylori infection rarely occurred in Korean adults, with a rate of 3.1%. However, no independent risk factors for new infection were identified.

INTRODUCTION

Helicobacter pylori infection is associated with several gastrointestinal disorders, such as gastric ulcers, duodenal ulcers, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. It is also associated with extragastrointestinal disorders including idiopathic thrombocytopenic purpura [1]. The prevalence of H. pylori infection varies significantly worldwide depending on the region, and the number of infected individuals is estimated to be approximately 4.4 billion, which is approximately half of the global population [2]. The prevalence of H. pylori infection has been gradually decreasing, and the seroprevalence rates of H. pylori infection in asymptomatic Korean adults have been reported to be 66.9% in 1998, 59.6% in 2005, 54.4% in 2011, and 43.9% in 2016–2017 [3]. The criteria for the Korean National Health Insurance Service medical care benefits for H. pylori treatment have gradually expanded [4]. As a result, a decrease in the prevalence of H. pylori infection is expected to be accompanied by a reduction in related diseases, including gastric cancer.

H. pylori infection is known to occur primarily during childhood, mainly through oral-oral or oral-fecal routes [5]; however, it also occurs consistently in the adult population [6]. The new H. pylori infection incidences in the adult population have been reported to vary depending on economic status and are lower in developed countries at 0.5%–1.1% per year than in less developed countries at 3%–10% [7,8]. New H. pylori infections in the adult population could have long-term effects on the development of peptic ulcers, MALT lymphoma, and gastric cancer. Previous studies have reported an association between H. pylori reinfection and the recurrence of MALT lymphoma and peptic ulcers in patients with successfully eradicated H. pylori infection [9]. Investigating the occurrence of new H. pylori infections and related factors in the adult population is important for managing conditions related to H. pylori infection.

Studies investigating new H. pylori infections in the adult population in Korea are rare. In previous studies, the occurrence of new H. pylori infections was evaluated by serological test (H. pylori IgG antibody test), and the seroconversion rate in Korean adults who were initially H. pylori IgG antibody test-negative was found to be around 2.1%–3.3% per year [10-12]. However, the serological test does not accurately reflect current H. pylori infection owing to false-negative results.

Thus, we evaluated new H. pylori infections using the urea breath test (UBT) and the associated risk factors in healthy Korean adult participants who were initially confirmed to be negative for H. pylori infection.

METHODS

Study design and participants

This was a prospective observational study involving healthy adults aged 40 years and older, who participated in the National Cancer Screening Program for gastric cancer at the National Cancer Center from November 2007 to December 2014. Eligible participants tested negative for H. pylori infection, as confirmed by both histological test and rapid urease test (RUT). Participants who had received treatment for H. pylori infections, undergone a previous gastrectomy, or undergone endoscopic resection for gastric adenoma or early gastric cancer were excluded. All participants were adequately informed of the research purpose, methods, and content. Informed consent was obtained from each participant, and the study was approved by the Institutional Review Board of the National Cancer Center (Approval No: NCC2015-0170).

Assessment of H. pylori infection status

The initial H. pylori infection status of participants was determined by both histological test and RUT. We obtained two biopsy specimens each from the corpus lesser curvature, corpus greater curvature, and antrum lesser curvature. Hematoxylin-eosin staining and Wright-Giemsa staining of the specimens were performed to evaluate H. pylori infection status histologically. Additionally, one biopsy sample taken from the corpus greater curvature was used for the RUT (Pronto Dry®, Gastrex Sarl), which featured a dipstick saturated with urea and a pH indicator (phenol red). A single biopsy sample was inserted into the RUT kit, and the colorimetric change (from yellow to red) was evaluated after a 60-minute incubation period. In this study, negative H. pylori infection was defined if all histological tests at all biopsy sites and the RUT were negative.

The follow-up H. pylori infection status of the participants was determined using a single UBT from August 2015 to December 2017. For the UBT, patients were required to fast for at least 4 hours on the day of examination. To prevent false-negative results, antibiotics and bismuth compounds were discontinued for at least 2–4 weeks, and antacids, including proton pump inhibitors, were discontinued for at least 2 weeks prior to the test. A positive UBT result was defined as a difference of ≥2‰ between the 13C/12C value of the baseline sample and that of the sample collected 20 minutes later.

Collection of clinical characteristics and questionnaire

Clinical information and questionnaire data were collected from the participants to evaluate the risk factors associated with new H. pylori infection. The clinical data included age, sex, endoscopic diagnosis, and pathological information on the severity of atrophic gastritis and intestinal metaplasia. The severity of atrophic gastritis and intestinal metaplasia was graded as absent, mild, moderate, or marked, by a single specialized gastrointestinal pathologist, according to the Updated Sydney System [13].

A questionnaire was administered during the gastric cancer screening endoscopy. The questionnaire items included participant demographics (place of birth, current residence, education level, and economic status), health status (medical history, history of antibiotic use, and surgical history), H. pylori infection status of the spouse, smoking history, alcohol consumption, number of cohabiting family members, and number of preschool children.

Study outcomes and statistical analysis

The primary outcome was the new H. pylori infection rate at the follow-up visit. The annual rate of new H. pylori infections was determined based on the number of new infections during the mean follow-up period. Factors associated with the new H. pylori infection were investigated as secondary outcomes.

Data were presented as number (%) or median (interquartile range [IQR]). Continuous variables were analyzed using the Mann–Whitney U test, while categorical variables were analyzed using the chi-square test or Fisher’s exact test. A logistic regression model was used to analyze factors associated with new H. pylori infection. Variables that were statistically significant (p<0.05) in univariate analysis were included as covariates in multivariate analysis. All statistical analyses were performed using STATA version 17.0 (StataCorp). Statistical significance was defined as a two-sided p-value <0.05.

RESULTS

Participant baseline characteristics

From November 2007 to December 2014, 200 participants who tested negative for H. pylori infection after undergoing gastric cancer screening endoscopy via the National Cancer Screening Program agreed to participate in this study. Of these, 8 participants were excluded because of incomplete questionnaire data (n=5), no follow-up UBT (n=2), or treatment with endoscopic submucosal dissection for early gastric cancer (n=1). Finally, 192 participants were included in this study (Fig. 1).

Fig. 1.

Study flowchart.

The median age of the participants was 56 years (IQR, 50–60 years), and 68 were male (35.4%). When comparing baseline characteristics according to new H. pylori infection status, there were no statistically significant differences in age, sex, hypertension, diabetes mellitus, smoking history, alcohol consumption, area of residence, education level, cohabitation with children aged ≤7 years, or the number of people sharing a bedroom (Table 1). The proportion of participants without atrophic gastritis at the corpus lesser curvature was significantly lower in the new infection group (66.7%) than in the persistently negative group (95.2%) (p=0.017). Similarly, the proportion of participants without intestinal metaplasia at the same site was lower in participants with new infection than in those persistently testing negative (66.7% vs. 94.6%; p=0.028).

Comparison of baseline characteristics according to new H. pylori infection status

New H. pylori infection rate

During a mean follow-up period of 4.1 years (standard deviation: 2.1 years), new H. pylori infections were detected in 6 of the 192 participants (3.1%), corresponding to an annual new infection rate of 0.76%. In the analysis by age group, the rate of new H. pylori infections was low among participants in their 40s (2.4%, 1/42), 50s (1.1%, 1/94), and 60s (2.2%, 1/45), whereas it was significantly higher in those aged 70 years or older (27.3%, 3/11) (p=0.003) (Fig. 2).

Fig. 2.

New H. pylori infection rates by age group.

Factors associated with the new H. pylori infection

Logistic regression analysis was performed to identify factors associated with new H. pylori infection (Table 2). In the univariate analysis, age (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.02–1.26) and corpus atrophy (OR, 9.83; 95% CI, 1.59–60.98) were statistically significantly associated with new H. pylori infection. However, no significant factors associated with new infection were identified in the multivariate analysis.

Factors associated with new H. pylori infection

DISCUSSION

This single-center prospective observational study investigated the incidence of new H. pylori infections in healthy Korean adults who initially tested negative for infection. The results showed that new H. pylori infection occurred in 6 of the 192 participants (3.1%), corresponding to an annual infection rate of 0.76%. Upon analyzing the factors associated with new H. pylori infection using clinical and questionnaire data, increasing age and corpus atrophy were identified as significant factors in the univariate analysis; however, no significant factors were found in the multivariate analysis.

Most previous studies investigating new H. pylori infections in the adult population have estimated the seroconversion rate using serum H. pylori IgG antibody tests [7,10-12,14]. Studies from other countries have reported annual H. pylori IgG seroconversion rates of 0.3%–0.7% in developed countries [7,14], whereas rates are as high as 1.9%–7.5% in developing countries [7]. Previous Korean studies involving healthy adults have reported higher new infection rates than those in developed countries. Kim et al. [10] reported an annual seroconversion rate of 2.1% after observing antibody conversion in 17 (12.8%) of 133 seronegative men aged 40–60 years. The study had limitations in estimating the new infection rate in the general Korean population because it was restricted to male participants and targeted subway workers, who may have been at a higher risk of infection due to frequent close contact with large populations [10]. Jung et al. [11] identified 24703 seronegative participants from a cohort of 67212 health screening participants aged 20 years or older and reported that 2897 participants (11.7%) became seropositive during follow-up, corresponding to an annual seroconversion rate of 2.8%. Another study involving 407 participants screened for seronegative gastric cancer observed seroconversion in 61 individuals (15%), resulting in an annual seroconversion rate of 3.3% [12]. Although the H. pylori IgG antibody test is a noninvasive method suitable for large-scale epidemiological studies, it cannot easily distinguish between current and past infections. Consequently, it may diagnose a higher number of infected individuals than those requiring treatment (i.e., those with current infection).

In the present study, we included only healthy adults who underwent upper endoscopy as part of the National Cancer Screening Program and were confirmed to be free of current H. pylori infection based on negative histology and RUT results. At the follow-up visit, new H. pylori infections were diagnosed using the UBT instead of the serum H. pylori IgG antibody test. Consequently, the annual rate of new H. pylori infections was 0.76%, which was lower than the annual H. pylori IgG seroconversion rates of 2.1%–3.3% reported in previous Korean studies [10-12]. Similarly, in a study by Kim et al. [12], while 61 of 407 participants (15.0%) showed H. pylori IgG seroconversion, only 6 of these 61 participants (9.8%; 1.5% of the total participants) were confirmed to have a current infection via histology or UBT. The incidence of new H. pylori infections in the Korean adult population was low. However, owing to its potential false-positive test results, the H. pylori IgG antibody test is unsuitable for identifying participants with current infections requiring eradication therapy. Therefore, additional confirmatory tests such as UBT, RUT, or histology are necessary.

The prevalence of H. pylori infection in Korea, assessed using the serum IgG antibody measurement, decreased from 66.9% in 1998 to 43.9% in 2016–2017 [3]. This decline is believed to be associated with improvements in the country’s socioeconomic status and hygiene conditions [3]. Furthermore, the annual new infection rate after successful H. pylori eradication in Korea decreased from 7.5%–12.8% in studies from the 1990s to 2.0%–6.5% in studies from the 2010s [15-19], reaching a level comparable to the 1.7%–6.2% reported in developed countries [20,21]. Although the incidence of new infections in H. pylori-negative adults is hypothesized to follow a decreasing trend similar to that of overall H. pylori seroprevalence, confirming this is difficult owing to the paucity of relevant studies. Despite differences in diagnostic methods between our study and previous studies, the annual new infection rate of 0.76% observed in our study was low, approaching the 0.3%–0.7% range reported in developed countries. However, given that new H. pylori infection after successful eradication is clinically associated with the recurrence of H. pylori-related diseases [9,15,22], it is necessary to identify high-risk groups for new infections among confirmed H. pylori-negative adults and conduct follow-up monitoring of their infection status.

The reported risk factors associated with new H. pylori infection in adults include increasing age [6,11,23], low socioeconomic status [7,11], low education level [11,23], high family crowding [23], H. pylori infection in family members [11,23], being married [11], smoking [11], excessive alcohol consumption [11], and a history of endoscopy [14]. In the present study, we analyzed the risk factors associated with new H. pylori infection in adults. The univariate analysis identified increasing age and corpus atrophy as risk factors associated with new infection. Although the prevalence of corpus atrophy was higher in participants with new confirmed H. pylori infection, these participants were older than those without infection (median age: 68 years vs. 51 years), suggesting that this finding may be an age-related change. In the multivariate analysis, including age and corpus atrophy, no significant risk factors for new H. pylori infection were identified. This is likely because we diagnosed new H. pylori infections using the UBT rather than the H. pylori IgG antibody test, which resulted in an insufficient number of new infection cases to identify statistically significant factors.

This study had several limitations. First, we confirmed the H. pylori-negative infection status through both RUT and histology from three biopsy sites. In addition, to minimize false-negative test results, the biopsy specimen for the RUT was obtained from the corpus greater curvature, where the frequency and severity of atrophic gastritis and intestinal metaplasia are the lowest. However, the possibility of false-negative test results cannot be completely avoided. Second, we selected only a small number of participants whose previously negative H. pylori status could be verified from medical records. Therefore, a selection bias cannot be completely ruled out, and the generalizability of our findings may be limited. Third, because follow-up tests were not performed at regular intervals from the time of initial negative confirmation, but rather a single UBT was conducted during the study period, it was difficult to confirm the exact timing of the new infection. Fourth, the study participants self-reported no prior history of H. pylori eradication therapy in the questionnaire. However, we cannot completely rule out the possibility of including patients whose H. pylori infections were eradicated by previous antibiotic treatments. Finally, given the small number of new H. pylori infection cases, the multivariate analysis conducted to identify the associated factors should be considered exploratory. Further studies with larger cohorts are required to evaluate the risk factors.

In conclusion, the rate of new H. pylori infections in the adult population was low (3.1%). However, owing to the low rate of new H. pylori infections, it was difficult to identify the risk factors associated with new infection. Therefore, nationwide multicenter studies are needed to identify the risk factors for new H. pylori infection in the Korean adult population. Furthermore, the impact of new H. pylori infection on associated diseases, such as gastric cancer and peptic ulcers, requires further evaluation.

Notes

Availability of Data and Material

The datasets that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Conflicts of Interest

Young-Il Kim, a contributing editor of the Korean Journal of Helicobacter and Upper Gastrointestinal Research, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.

Funding Statement

This work was supported by grants from the National Cancer Center (grant number: 2510850).

Acknowledgements

None

Authors’ Contribution

Conceptualization: Il Ju Choi. Data curation: all authors. Formal analysis: Young-Il Kim, Il Ju Choi. Funding acquisition: Il Ju Choi. Investigation: all authors. Supervision: all authors. Writing—original draft: Young-Il Kim, Il Ju Choi. Writing—review & editing: all authors. Approval of final manuscript: all authors.

References

1. Crowe SE. Helicobacter pylori infection. N Engl J Med 2019;380:1158–1165.
2. Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017;153:420–429.
3. Lim SH, Kim N, Kwon JW, et al. Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: a cross-sectional nationwide multicenter study. PLoS One 2018;13e0204762.
4. Kim YI, Choi IJ. Criteria for the national health insurance service medical care benefit of Helicobacter pylori treatment. Korean J Helicobacter Up Gastrointest Res 2022;22:235–239.
5. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175–1186.
6. Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102:41–46.
7. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:559–578.
8. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9(Suppl 2):45–51.
9. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005;100:2083–2099.
10. Kim N, Lim SH, Lee KH, et al. Seroconversion of Helicobacter pylori in Korean male employees. Scand J Gastroenterol 2005;40:1021–1027.
11. Jung JH, Choi KD, Han S, et al. Seroconversion rates of Helicobacter pylori infection in Korean adults. Helicobacter 2013;18:299–308.
12. Kim YJ, Lee SY, Kim JH, Sung IK, Park HS. Incidence of infection among subjects with Helicobacter pylori seroconversion. Clin Endosc 2022;55:67–76.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–1181.
14. Kikuchi S, Ohgihara A, Hasegawa A, Miki K, Kaneko E, Mizukoshi H. Seroconversion and seroreversion of Helicobacter pylori antibodies over a 9-year period and related factors in Japanese adults. Helicobacter 2004;9:335–341.
15. Kim N, Lim SH, Lee KH, Jung HC, Song IS, Kim CY. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 1998;27:321–326.
16. Kim N, Oh JH, Lee CG, et al. Effect of eradication of Helicobacter pylori on the benign gastric ulcer recurrence--a 24 month follow-up study. Korean J Intern Med 1999;14:9–14.
17. Kim MS, Kim N, Kim SE, et al. Long-term follow up Helicobacter pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy. BMC Gastroenterol 2013;13:138.
18. Kim MS, Kim N, Kim SE, et al. Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter 2013;18:135–142.
19. Kim SY, Hyun JJ, Jung SW, Koo JS, Yim HJ, Lee SW. Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection. Helicobacter 2014;19:202–206.
20. Yan TL, Hu QD, Zhang Q, Li YM, Liang TB. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment Pharmacol Ther 2013;37:963–968.
21. Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther 2017;46:773–779.
22. Seo M, Okada M, Shirotani T, et al. Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. J Clin Gastroenterol 2002;34:129–134.
23. Zhou XZ, Lyu NH, Zhu HY, et al. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut 2023;72:855–869.

Article information Continued

Fig. 1.

Study flowchart.

Fig. 2.

New H. pylori infection rates by age group.

Table 1.

Comparison of baseline characteristics according to new H. pylori infection status

Characteristics New H. pylori infection
p-value
No (n=186) Yes (n=6)
Age (yr) 51 (51–60) 68 (50–72) 0.076
Sex 0.188
 Male 64 (34.4) 4 (66.7)
 Female 122 (65.6) 2 (33.3)
Co-morbid illness
 Hypertension 27 (14.5) 1 (16.7) >0.999
 Diabetes mellitus 7 (3.8) 0 (0) >0.999
Endoscopic diagnosis 0.049
 Normal 103 (55.4) 1 (16.7)
 Gastritis 60 (32.3) 3 (50.0)
 Reflux esophagitis 13 (7.0) 0 (0)
 Peptic ulcer disease 9 (4.8) 2 (33.3)
 Gastric subepithelial tumor 1 (0.5) 0 (0)
Smoking 0.353
 Never 135 (75.6) 3 (50.0)
 Former or current smoker 51 (27.4) 3 (50.0)
Alcohol drinking 0.483
 Never 89 (47.8) 2 (33.3)
 Former or current drinker 97 (52.2) 4 (66.7)
Residency >0.999
 Metropolitan or small city 183 (98.4) 6 (100)
 Rural area 3 (1.6) 0 (0)
Education 0.402
 Less than high school 61 (32.8) 3 (50.0)
 High school graduate or more 125 (67.2) 3 (50.0)
Child (≤7 years) in house 3 (1.6) 0 (0) >0.999
Household crowding >0.999
 1 subject per room 54 (29.0) 2 (33.3)
 2 subjects per room 128 (68.8) 4 (66.7)
 ≥3 subjects per room 4 (2.2) 0 (0)
Atrophic gastritis at the antrum* 0.071
 Absent 129 (69.7) 3 (50.0)
 Mild 45 (24.3) 1 (16.7)
 Moderate 8 (4.3) 1 (16.7)
 Marked 3 (1.6) 1 (16.7)
Atrophic gastritis at the corpus LC 0.017
 Absent 177 (95.2) 4 (66.7)
 Mild 5 (2.7) 1 (16.7)
 Moderate 3 (1.6) 0 (0)
 Marked 1 (0.5) 1 (16.7)
Intestinal metaplasia at the antrum 0.141
 Absent 159 (85.5) 4 (66.7)
 Mild 22 (11.8) 1 (16.7)
 Moderate 2 (1.1) 0 (0)
 Marked 3 (1.6) 1 (16.7)
Intestinal metaplasia at the corpus LC 0.028
 Absent 176 (94.6) 4 (66.7)
 Mild 7 (3.8) 1 (16.7)
 Moderate 2 (1.1) 0 (0)
 Marked 1 (0.5) 1 (16.7)

Values are presented as mean (interquartile range) or n (%).

*

Atrophy grade could not be evaluated in one participant without new H. pylori infection.

LC, lesser curvature.

Table 2.

Factors associated with new H. pylori infection

No. of subject Univariate analysis*
Multivariate analysis*
cOR 95% CI p-value aOR 95% CI p-value
Age 192 1.13 1.02–1.26 0.022 1.10 0.98–1.23 0.115
Sex
 Male 68 1.00
 Female 124 0.26 0.05–1.47 0.128
Hypertension 28 1.18 0.13–10.48 0.883
Diabetes mellitus 7 NA - -
Smoking
 Never 138 1.00
 Former or current smoker 54 2.65 0.52–13.54 0.242
Alcohol drinking
 Never 91 1.00
 Former or current drinker 101 1.80 0.33–9.84 0.497
Residency
 Metropolitan or small city 189 1.00
 Rural area 3 NA - -
Education
 Less than high school 64 1.00
 High school graduate or more 128 0.49 0.10–2.49 0.388
Child (≤7 years) in house
 No 189 1.00
 Yes 3 NA - -
Household crowding
 1 subject per room 56 1.00
 ≥2 subjects per room 136 0.82 0.15–4.60 0.820
Atrophic gastritis at the antrum
 No 132 1.00
 Yes 59 2.30 0.45–11.77 0.316
Atrophic gastritis at the corpus LC
 No 181 1.00 1.00
 Yes 11 9.83 1.59–60.98 0.014 3.97 0.48–32.67 0.200
*

Logistic regression model was used for analyses.

aOR, adjusted odds ratio; CI, confidence interval; cOR, crude odds ratio; NA, not applicable; LC, lesser curvature.